Together, these findings demonstrate that Fancc-/-;Mad2+/- mice rapidly develop lethal AML and are predisposed to develop cancer much earlier in life than either Fancc-/- or Mad2+/- mice. The gene discussed is MAD2L1; the disease is acute myeloid leukemia.